Erratum: Amelioration of sepsis by inhibiting sialidase-mediated disruption of the CD24-SiglecG interaction (Nature Biotechnology (2011) 29 (428-435))

Guo Yun Chen, Xi Chen, Samantha King, Karen A. Cavassani, Jiansong Cheng, Xincheng Zheng, Hongzhi Cao, Hai Yu, Jingyao Qu, Dexing Fang, Wei Wu, Xue Feng Bai, Jin Qing Liu, Shireen A. Woodiga, Chong Chen, Lei Sun, Cory M. Hogaboam, Steven L. Kunkel, Pan Zheng, Yang Liu

Research output: Contribution to journalArticle

Original languageEnglish (US)
Pages (from-to)193
Number of pages1
JournalNature Biotechnology
Volume30
Issue number2
DOIs
StatePublished - Feb 2012
Externally publishedYes

ASJC Scopus subject areas

  • Applied Microbiology and Biotechnology
  • Biotechnology
  • Molecular Medicine
  • Bioengineering
  • Biomedical Engineering

Cite this

Chen, G. Y., Chen, X., King, S., Cavassani, K. A., Cheng, J., Zheng, X., Cao, H., Yu, H., Qu, J., Fang, D., Wu, W., Bai, X. F., Liu, J. Q., Woodiga, S. A., Chen, C., Sun, L., Hogaboam, C. M., Kunkel, S. L., Zheng, P., & Liu, Y. (2012). Erratum: Amelioration of sepsis by inhibiting sialidase-mediated disruption of the CD24-SiglecG interaction (Nature Biotechnology (2011) 29 (428-435)). Nature Biotechnology, 30(2), 193. https://doi.org/10.1038/nbt0212-193b